FDA approves Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) for the treatment of presbyopia in adults – Tenpoint Theraputics
Tenpoint Therapeutics, Ltd., announced that the FDA approved Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as Brimochol PF, the first and only dual-agent eye drop… read more.
